2 F c.499C>T (Q96X) Bilateral Positive (retinal) Positive
PatientID: 2
KindredID: 2
Case: F, Age Unknown, Ethnicity Unknown
DiseaseAssertion: VHL
FamilyInfo: N/A
CasePresentingHPOs: HP:0000107; HP:0005584; HP:0009711; HP:0001737 (Renal cyst, Renal cell carcinoma, Retinal capillary hemangioma, Pancreatic cysts)
CaseHPOFreeText: Bilateral RCC and renal cysts, retinal hemangioblastoma, positive for pancreatic cysts.
CaseNotHPOs: N/A
CaseNotHPOFreeText: N/A
CasePreviousTesting: N/A
PreviouslyPublished: N/A
SupplementalData: Table 1
Variant: p.Q96* (c.286C>T)
LegacyVariant: c.499C>T (Q96X)
CaseProblemVariantFreeText: N/A
ClinVarID: 428804, https://www.ncbi.nlm.nih.gov/clinvar/variation/428804/
CAID: N/A
gnomAD: N/A
VariantEvidence: Variant is declared as “c.499C>T (Q96X)” by the authors, this was treated as a legacy variant and mapped to c.286C>T, Q96*. This study found coexpression of Epo and EpoR in 11 RCCs and in 10 benign renal cysts in a spectrum of VHL renal disease suggesting that Epo/EpoR coexpression is present in both benign and malignant stages of renal neoplasia. Six benign cysts stained for Epo but not EpoR. The researchers detected loss of heterozygosity of a wild-type VHL allele in different RCCs with microsatellite markers, D3S1110 and D3S2452, flanking the VHL gene
MutationType: stop_gained; missense_variant;transition
CivicName: Q96* (c.286C>T)
MultipleGeneVariants: N/A